An artificial-intelligence approach created at Carolina could help bring new drugs to patients quicker.
An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.
The system is called Reinforcement Learning for Structural Evolution, known as ReLeaSE, and is an algorithm and computer program that comprises two neural networks which can be thought of as a teacher and a student. The teacher knows the syntax and linguistic rules behind the vocabulary of chemical structures for about 1.7 million known biologically active molecules. By working with the teacher, the student learns over time and becomes better at proposing molecules that are likely to be useful as new medicines.
Alexander Tropsha, Olexandr Isayev and Mariya Popova, all of the UNC Eshelman School of Pharmacy, are the creators of ReLeaSE. The University has applied for a patent for the technology, and the team published a proof-of-concept study in the journal Science Advances last week.
“If we compare this process to learning a language, then after the student learns the molecular alphabet and the rules of the language, they can create new ‘words,’ or molecules,” said Tropsha. “If the new molecule is realistic and has the desired effect, the teacher approves. If not, the teacher disapproves, forcing the student to avoid bad molecules and create good ones.”
ReLeaSE is a powerful innovation to virtual screening, the computational method widely used by the pharmaceutical industry to identify viable drug candidates. Virtual screening allows scientists to evaluate existing large chemical libraries, but the method only works for known chemicals. ReLeASE has the unique ability to create and evaluate new molecules.
“A scientist using virtual screening is like a customer ordering in a restaurant. What can be ordered is usually limited by the menu,” said Isayev. “We want to give scientists a grocery store and a personal chef who can create any dish they want.”
The team has used ReLeaSE to generate molecules with properties that they specified, such as desired bioactivity and safety profiles.The team used the ReLeaSE method to design molecules with customized physical properties, such as melting point and solubility in water, and to design new compounds with inhibitory activity against an enzyme that is associated with leukemia.
“The ability of the algorithm to design new, and therefore immediately patentable, chemical entities with specific biological activities and optimal safety profiles should be highly attractive to an industry that is constantly searching for new approaches to shorten the time it takes to bring a new drug candidate to clinical trials,” said Tropsha.
Receive an email update when we add a new DRUG DESIGN article.
The Latest on: Drug design
via Google News
The Latest on: Drug design
- Advancing the description of 'mysterious' water to improve drug design on December 17, 2018 at 9:29 am
Interactions with water dominate how drug molecules bind to targets, but it's tricky to model these interactions, limiting the accuracy of drug design. In a recent paper in The Journal of Chemical ... […]
- Demi Lovato Is All Smiles On Dinner Date With Fashion Designer Henry Levy Months After Drug Overdose: Photo on December 9, 2018 at 11:18 am
Things are looking up for Demi Lovato! The “Confident” songstress appeared happy and healthy as she stepped out to dinner with Henry Levy in Malibu on Saturday, December 8, four months after a drug ov... […]
- Drug Design Defect Litigation Faces Its Demise on December 5, 2018 at 10:01 am
"The Demise of Drug Design Litigation: Death by Federal Preemption" is the intriguing title of the latest law review article written by the “Rabbi of Torts,” Prof. Aaron Twerski (we’re not making this ... […]
- ETCADA: Designer drug flakka not turning up in Northeast Texas on December 3, 2018 at 5:39 pm
A man walking in traffic lanes on U.S. 59 north of Carthage one day last month turned violent against the sheriff’s deputy trying to coax him to safety. The designer drug “flakka” was blamed for the m... […]
- The Demise of Drug Design Litigation: Death by Federal Preemption on December 3, 2018 at 4:55 pm
That is the intriguing title of the latest law review article written by the “Rabbi of Torts,” Prof. Aaron Twerski (we’re not making this up, Prof. Twerski’s Wikipedia page is the fifth result when we ... […]
- Arming drug hunters, chemists design new reaction for drug discovery on November 15, 2018 at 11:23 am
If pharmaceutical chemists are the drug hunters who discover new medicines, scientists like Andrew McNally and Robert Paton are the armorers—the deft creators who arm drug hunters with the sharpest to... […]
- Arming drug hunters, chemists design new reaction for drug discovery on November 15, 2018 at 11:04 am
The left image is a modification of the antihistamine drug loratadine made via the pyridine-pyridine coupling method developed by CSU chemists. The bold line represents the reaction, the result of ... […]
- Drug design: Clues for drugging the 'undruggable' on November 5, 2018 at 1:56 pm
Scientists have shown how thalidomide analogs mediate degradation of many more proteins than previously anticipated. These proteins -- zinc finger transcription factors -- play a role in cancer and de... […]
- FDA Blasts Data, Trial Design For Alkermes Depression Drug on October 30, 2018 at 9:25 am
The FDA this morning has issued a scathing review of an experimental drug that could be, if the agency ends up approving it next year, a new option for the millions of Americans who struggle with depr... […]
via Bing News